Genetic Weight Loss Test Reveals “Hungry Gut” Risk Score – Are You a Match for New Injection Medications?
Washington, DC – A new genetic risk score known as “hungry gut” could potentially revolutionize weight loss treatments by helping individuals determine how well they may respond to injected medications. The effectiveness of popular GLP-1 medications for weight loss has puzzled researchers, with some individuals experiencing substantial weight loss while others see minimal results. A recent study highlighted that about 1 in 7 individuals using semaglutide for over a year did not lose at least …